1. Alexander, J. and Vickerman, K. 1975, Fusion of host cell secondary lysosomes with the parasitophorous vacuoles of Leishmania mexicana-infected macrophages, J. Protozool., 22:502.
2. Alving, C.R. 1982, Therapeutic potential of liposomes as drug carriers in leishmaniasis, malaria and vaccines. In: “Targeting of Drugs”, Gregoriadis, G., Senior, J. and Trouet, A., eds., Plenum, New York.
3. Alving, C.R. 1984, Delivery of liposome-encapsulated drugs to macrophages, Pharmacol. Therapeutics (in press).
4. Alving, C.R. and Steck, E.A. 1979, The use of liposome-encapsulated drugs in leishmaniasis, Trends Biochem. Sci., 4:N175.
5. Alving, C.R. and Swartz, Jr., G.M. 1984, Preparation of liposomes for use as drug carriers in treatment of leishmaniasis, in: “Liposome Technology”, Gregoriadis, G., CRC Press, Boca Raton.